Citadel Advisors - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is and the CUSIP is 761330909. A total of 2 filers reported holding REVANCE THERAPEUTICS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2016$141,00010,4000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2016
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 36,400$1,032,0000.00%
SIMPLEX TRADING, LLC 226$640,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REVANCE THERAPEUTICS INC shareholders